NIPRO MEDICAL EUROPE financials
A multi-period view of the public annual-account figures reported for NIPRO MEDICAL EUROPE, with comparable measures and links to available source documents.
Company overviewRegistry number
0444276727
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for NIPRO MEDICAL EUROPE
2025 versus 2024
- Operating line
- €385,885,256
- EBITDA
- €10,879,250
- Total assets
- €324,746,850
- Equity
- €78,181,764
+6.9%
-44.7%
-5.2%
-3.8%
EBITDA margin +2.8% · Equity ratio +24.1%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €385,885,256 | €10,879,250 | €324,746,850 | €78,181,764 | - |
| 202431 Dec 2024 | €361,116,776 | €19,659,319 | €342,517,008 | €81,234,653 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.